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Abstract  
Background: Post burn pruritus is a syndrome of stressful symptoms that is pervasive and occurs in 
over 90% of burn patients and continues for years after the burn has healed.  Post burn pruritus is 
experienced by burn survivors that may require medical management and effective interventions. 
Purpose: This article is to show how to relieve post burn pruritus effectively by developing a post 
burn pruritus relief protocol.  Design: A descriptive literature review was conducted and relevant 
empirical articles written during the year of 2000 to 2014 were appraised to create a post burn 
pruritus relief protocol.  Twenty seven out of 79 articles were selected using pre-established inclusion 
criteria: any age group experiencing burn related pruritus after second or third degree burns.  Data 
bases were Cochrane Central Register of Controlled Trials, CINAHL, EBSCO, PubMed, the 
National Guideline Clearinghouse, google scholar, and the American Burn Association web site. 
Conclusions: This protocol included both non-pharmacological and pharmacological interventions 
that have been delineated for use and was developed to apply based on the healing stage: pre-healing, 
healing, and post-healing.      
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Introduction 
Post burn pruritus (PBP), a severe itching sensation associated with burn injury, has been 
identified as one of the most debilitating symptoms post burn survivors experience (Ahuja, 
Gupta, R., Gupta, G., & Shrivastava, 2011; Carrougher et al., 2013; Goutos, 2010; Goutos et al., 
2010; Otene & Omuma-egbu, 2013).  Pruritus appears the first two weeks following burn injury 
(Ahuja et al., 2011; Goutos et al., 2010).  The prevalence of post burn pruritus has been noted in 
over 90% of burn patients and can persist in greater than 40% of patients for four to ten years 
after burn injury (Carrougher et al., 2013).  Several studies showed the incidence of onset of post 
burn pruritus varies from 80%-100% with the onset during the early healing phase and sustaining 
for many years after injury (Ahuja & Gupta, 2013; Baker et al., 2001; Whitaker, 2001).  
Research findings have recurrently proposed that PBP management should be one of the top 
priorities for burn research (Bell & Gabriel, 2009; Brooks et al., 2008).  Burn associated pruritus, 
when persistent, can cause disabling symptoms such as sleep disturbances, anxiety, and 
interruption in daily activities (Goutos et al., 2009).  
Although pruritus in post burn patients is well recognized, there is no consensus on 
standardized treatment (Bell & Gabriel, 2009; Otene & Onumaegbu, 2013; Richardson, Upton, 
& Rippon, 2014).  Single treatment may be ineffective, but most often therapies focus on either 
pharmacological or non-pharmacological interventions.  However, pharmacological 
interventions have adverse effects in some population with kidney problems, liver diseases or 
allergies to specific medicines, which causes pharmacological interventions to be limited to use.  
Therefore, the purpose of conducting this literature review was to establish a protocol for PBP 
relief with the integration of evidence based practices, primarily focused on non-pharmacological 
interventions.   
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Literature Search 
A keyword search was performed to identify relevant literature via Cochrane Central 
Register of Controlled Trials, CINAHL, EBSCO, PubMed, the National Guideline 
Clearinghouse, google scholar, and the American Burn Association web site.  The key words 
were burn(s), itching, and pruritus.  Due to limited publications, database searches were 
expanded to all peer reviewed and published studies written in English during the year of 2000 to 
2014, conducted with all second and third degree burn populations suffering from post-burn 
related pruritus.  As a result, 79 articles were initially listed from search engines and 26 out of 79 
articles were found relevant to the purpose of this review, developing a post burn pruritus relief 
protocol.   
Results 
The process of finalizing 26 relevant articles is shown through the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram (Figure 1).  All 
relevant articles for the treatment of PBP were summarized including the study design, setting, 
result, and limitation (Table 1).  Treatments are categorized in pharmacological and non-
pharmacological interventions.   
Pharmacological Interventions 
Thirteen out of 26 articles identified pharmacological effects on PBP that included both 
single oral medicine use and two or three combining oral medicine.  Examples of effective oral 
pharmacological interventions include 1) pregabalin (Lyrica®) alone; 2) gabapentin 
(Neurontin®, Gralise®, Horizant®, Fanatrex FusePag®) alone; 3) pregabalin and two different 
antihistamines (histamine1 [H1] and histamine2 [H2] blockers); 4) gabapentin and one 
antihistamine (H1 blocker); 5) gabapentin and two different antihistamines; and 6) combination 
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of two different antihistamines.  According to the randomized controlled trial (RCT) by Ahuja 
and Gupta (2013), pregabalin alone or combination of two kinds of antihistamines decreased 
PBP but adding more antihistamines did not decrease PBP additionally.  Gabapentin alone or 
combination of one or two antihistamines reduced PBP in several studies (Ahuja et al., 2011; 
Goutos et al., 2010; Mendham, 2004).  Combination of two different antihistamines also lowered 
PBP more than using one antihistamine (Baker et al., 2001).  Two experimental studies show 
naltrexone (Vivitrol®, Revia®, Depade®) is supportive in decreasing duration and frequency of 
itching in patients with PBP and can be used before sleeping as a supplementary method to other 
anti-pruritic medicine (Jung et al., 2009; LaSalle, Rachelska, & Nedelec, 2007). 
Oral medications are more effective when given as scheduled than being given as needed 
(Baker et al., 2001).  However, oral pharmacological interventions have adverse effects.  For 
example, antihistamines are well known for drowsiness (Vallerand, Sanoski, & Deglin, 2016).  
Pregabalin has withdrawal symptoms such as insomnia, headache, agitation, nausea, anxiety, 
diarrhea, flu like symptoms, nervousness, major depression, pain, convulsions, hyperhidrosis, 
and dizziness when abruptly stopped (Vallerand et al., 2016).  In addition, most pharmacological 
interventions are not as effective as non-pharmacological interventions once wounds begin 
granulating towards the healing stage when pruritus is more concerned (Goutos, 2013).   
Administering topical agents in both healing and healed stages of wounds are beneficial 
to the population with PBP according to several researches (Campanati et al., 2013; Lewis et al., 
2012; Nedelec, Rachelska, Parnell, & LaSalle, 2012; Ogawa & Hyaku-soku, 2008).  Campanati 
et al. (2013) reported ozonated oil and hyaluronic acid gel applied to burn associated wounds 
decreased PBP.  The study by Ogawa and Hyaku-soku (2008) revealed medilixir and mugwort 
lotion were effective in relieving PBP.  Mugwort lotion is consisted of mugwort extract, l-
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menthol, absolute ethanol, and distilled water.  Provase® (Dimethicone) cream was also reported 
in relieving PBP (Nedelec et al., 2012).  Medilixir® (a beeswax and herbal oil cream) reduced 
PBP when applied to burn associated wounds (Lewis et al., 2012).  Moisturizing body shampoo 
showed effective decrease of PBP (Ratcliff et al., 2005).  Botulinum toxin (Botox®) is shown to 
reduce PBP effectively by using one time dose in those who failed in managing PBP with 
conventional therapies (Akhtar & Brooks, 2012).       
Non-pharmacological Interventions  
Another thirteen out of 26 articles reported non-pharmacological methods in relieving 
PBP.  Examples of effective non-pharmacological interventions included: massage therapy, laser 
therapy (either regular or low level laser [LLLT]), transcutaneous electrical nerve stimulation 
(TENS), triamcinolone acetonide phonophoresis (TAP), muscle relaxation, silicone gel sheeting 
(SGS), pressure garment (Unna boot®), and nanocrystalline silver (Acticoat®).  Most non-
pharmacological interventions showed anti-pruritic effects specifically during the healed stage of 
burn wounds, whereas massage and Benson muscle relaxation therapy can be used regardless of 
the stage of healing.    
The study by Gurol, Polat, and Akcay (2010), a single RCT, exhibited massage therapy to 
intact skin decreased PBP among adolescent burn patients at the early phase of burn injury (pre-
healing stage).  Experimental group’s itching level (range: 0-10) was averagely 6.1 before the 
message therapy and then significantly decreased to 2.5 whereas control group’s average itching 
level slightly decreased from 5.59 to 5.50 (Gurol et al., 2010).  They also showed this therapy 
significantly reduced anxiety and pain in the experimental group (Gurol et al., 2010).  There are 
three other studies showing effective reduction in PBP with message therapy applied directly to 
healed burn wounds (Cho et al., 2014; Field et al., 2000; Roh, Cho, Oh, & Yoon, 2007).  The 
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study by Cho et al. (2014), a RCT, showed massage therapy led to significant improvement in 
pain and itching as well as positive changes in scar characteristics.  Another RCT is the study by 
Field et al. (2000) reporting massage therapy resulted in the significant decrease in itching, pain, 
depression and anxiety among those with PBP.  Roh et al. (2007) conducted a RCT 
demonstrating massage therapy improved pruritus, scar status, and depression among burn 
patients.  The study by Farahani, Hekmatpou, and Khani (2013), a Quasi-experimental study 
reported Benson muscle relaxation therapy lowered PBP in any healing stages in burn Patients.  
The researchers supported Benson muscle relaxation therapy was significantly effective in 
relieving the pain, pruritus, and vital signs of patients suffering from burns (Farahani et al., 
2013).    
Gaida et al. (2003) showed LLLT significantly decreased PBP.  The study by Hultman, 
Edkins, Wu, Calvert, & Cairns (2013) demonstrated regular laser therapy relieved PBP 
effectively as well.  The experimental study by Hultman et al. (2013) was designed as pretest-
posttest.  The study’s control group was the intact skin of participants and the experimental 
group was the participants’ burn wounds (Hultman et al., 2013). 
TENS was proven to reduce itching in the patients suffering from PBP (Hettrick, 2014; 
Whitaker, 2001).  The pilot RCT by Hettrick (2014) stated TENS was significantly effective in 
PBP reduction when TENS was provided an hour per day for three weeks.  The case study by 
Whitaker (2001) revealed receiving TENS for nine hours a day for two weeks relieved pruritus 
that resulted in no need of treatment for itching after two weeks.  In detail, PBP decreased from 
100% to 0% after two week of TENS therapy (Whitaker, 2001).         
The RCT by Waked, Nagib, and Ashm (2013) reported TAP reduced PBP as effectively 
as TENS did.  In their study, 20 patients received TAP and another 20 students received TENS 
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(Waked et al., 203).  The effectiveness in relieving PBP in both groups was shown to be 
significantly positive, but there was no difference regarding the relief of PBP between two 
groups (Waked et al., 2013).     
A case study by Brooks, Phang, and Moazzam (2007) demonstrated two weeks of 
applying nanocrystalline silver to unhealed wound reduced PBP in five cases with different burn 
associated wound sizes.  This intervention was reported to decrease the pruritus from 7.4 to 3.1 
of visual analog scale (VAS), which means significant reduction in PBP (Brooks et al., 2007).  
The researchers also reported nanocrystalline silver improved wound healing as well as reduction 
in PBP (Brooks et al., 2007).   
Wearing SGS was reported as the effective way in reducing PBP (Li-Tsang, Lau, Choi, 
Chan, & Jianan, 2006; Li-Tsang, Zheng, & Lau, 2010).   The RCT by Li-Tsang et al. (2006) 
showed experimental group had significantly decreased itching compared to the control group.  
The study demonstrated participants wearing SGS also had significant improvement in scar 
thickness and pliability (Li-Tsang et al., 2006).  Another RCT by Li-Tsang et al. (2010) showed 
wearing pressure garment significantly reduced pruritus as well as SGS did.  The study also 
revealed that wound was significantly improved when both pressure garment and SGS were 
applied together (Li-Tsang et al., 2010).    
Development of the PBP Relief Protocol   
The outcome of this literature review was synthesized according to the best evidence 
based outcomes from both combined pharmacological and non-pharmacological interventions.  
Accordingly, a PBP relief protocol was developed (Figure 2).  This protocol was designed 
according to the three different stages of wound healing: pre-healing (no granulation tissue), 
healing (partly granulated tissue), and healed stages (scar formation) with recommended dosages 
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and period for each intervention (Table 2).  Non-pharmacological interventions were 
recommended before pharmacological interventions considering established effectiveness and 
possible adverse effects of pharmacological interventions. 
Utilization of the PBP Relief Protocol 
Each stage of wound healing can be managed by both non-pharmacological and 
pharmacological interventions.  Non-pharmacological interventions are less invasive and should 
be considered as the primary intervention.  On the other hand, pharmacological interventions are 
more invasive and should be used only as a supplement to potentiate the therapeutic effect of 
non-pharmacological interventions or to minimize possible adverse effects of pharmacological 
interventions. 
Since non-pharmacological interventions are versatile and can be combined with other 
non-pharmacological and pharmacological interventions, non-pharmacological interventions 
should be considered first.  So pharmacological interventions are recommended only when non-
pharmacological interventions are ineffective.  In this case, only single pharmacological 
intervention is initially to be used with any non-pharmacological interventions (Table 2).  When 
single pharmacological intervention is not effective, two or three different medication can be 
combined.  For example, at pre-healing stage, all non-pharmacological interventions (both 
massage and Benson muscle relaxation therapy) can be used with one or more pharmacological 
interventions (pregabalin alone, pregabalin and two antihistamines, gabapentin alone, gabapentin 
and one or two H1 blockers, or a combination of H1 and H2 blockers) (Figure 2).   
Discussion 
This post burn pruritus protocol is the first evidence based protocol that uses non-
pharmacological interventions as the primary method of choice to reduce PBP.  Non-
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pharmacological and Pharmacological interventions for PBP have been identified and presented 
in an easily understood protocol to improve patient outcomes and clinical practice.  
Recommended dosage and duration of each intervention are included to clearly guide clinicians 
(Table 2).  A rehabilitation nurse may utilize this protocol by encouraging patients to use non-
pharmacological interventions as a primary intervention for PBP in collaboration with 
interdisciplinary team members.   
This protocol was drawn from mostly RCTs which are the level II of evidence.  However, 
each individual therapy of non-pharmacological interventions has one to three literature support 
(Table 2).  Accordingly, clinicians need to validate the efficiency of this suggested protocol by 
conducting a pilot study for the patients suffering from PBP.  Their pilot study should 
demonstrate this protocol significantly relieved PBP.  The pilot study researchers can use the 5-D 
Itch Scale (Figure 3), the visual analog scale (Figure 4), and the Itch man scale as valid and 
reliable instruments for PBP (Elman, Hynan, Gabriel, & Mayo, 2010).  In addition, they need to 
validate the efficacy of this PBP protocol by determining if the protocol: 1) relieved pruritus 
discomfort; 2) reduced cognitive dysfunctions such as low concentration, agitation, anxiety, 
and/or flat affect; and 3) increased quality of life (QoL).   
Conclusion 
  This suggested protocol was developed to use non-pharmacological interventions 
primarily and pharmacological interventions as a secondary treatment.  Accordingly, this 
protocol can be beneficial to patients by minimizing possible adverse effects of oral medications.  
Another benefit of this protocol is to provide a wide range of interventions with recommended 
treatment dosages and period.  The rehabilitation nurse needs to play a key role in collaborating 
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with the interdisciplinary team to utilize this protocol.  However, the protocol needs to be 
verified through a pilot study ideally with a RCT design.   
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 Figure 1. Flow diagram for selection of studies 
 
 Figure 2. Post Burn Pruritus Relief Protocol          
  
Figure 3. 5 – D ITCH SCALE (Adopted from Elman, Hyman, Gabriel, & Mayo, 2010) 
 
 
 Figure 4. Visual Analog Scale (Adapted from Elman et al., 2010) 
 
Table 1. Table of Evidence  
 
No 
Authors 
(year) 
Setting/ 
Participants  
Study Design  
/ Intervention 
Time 
Characteristics of  
Burn Wound 
Itching 
assess- 
ment Tool Study Result & Limitations 
1 
Ahuja & 
Gupta 
(2012) 
  
Outpatient 
setting / 
80 Adult Burn 
pts  
RCT / 
 
28days 
TBSA > 5%, 2nd degree 
burns, & wound either in 
healing or healed  
VAS Pregabalin alone or combined w/antihistamine 
→ ↓ PBP  
Adding antihistamines does not decrease PBP 
Limitation: The study did not define end point of 
anti-pruritic therapy. 
2 
Ahuja et al.  
(2010) 
Department of 
burns / 
20 Burn pts w/ 
12-70 yrs old 
RCT / 
 
28days  
TBSA > 5%, 2nd  degree 
burns, over 80% of wound 
epithelialized or healed 
VAS Gabapentin alone or combination w/cetirizine → 
↓ PBP 
Certirizine only does not decrease PBP 
Limitaion: too small sample size, limited period 
of data collection, graft size more than 1% 
excluded, single site study. 
3 
Akhtar & 
Brooks 
(2012) 
 
Outpatient 
setting/ 
8 pts w/failure 
of managing 
PBP in the 
past 
Prospective& 
experimental 
study/ 
One time 
All healed areas after 2nd-
3rd degree burns 
VAS Botox → ↓ PBP in population who failed in 
managing PBP w/ conventional therapies. 
50% had no PBP within 2wks after Botox & no 
itching up to 9months after treatment. 
Limitation: Difficult to expect who will require 
multiple injections to control their symptoms. 
4 
Baker et al. 
(2001) 
 
Setting not 
stated/ 
17pts w/ 10-
60yrs of age  
Double 
blind, 
Crossover 
trial/16days 
Partial thickness & any % 
of TBSA burn.  
Not described in wound 
healing stage  
VAS Combining H1 & H2 antagonists: more effective 
in ↓PBP than H1 antagonist alone during the 
first stage of treatment. 
More effective to treat PBP w/ scheduled 
medication than as needed medication  
Limitation: Small size of sample, High attrition 
rate (47%) 
5 
Brooks et 
al.  
(2007) 
Inpatient & 
outpatint 
settings/ 
5cases 
Case study/ 
2weeks 
TBSA of 7-65% w/ 
unhealed burn wound 
VAS 2-week Acticoat® application is effective in 
↓PBP 
Limitation: This study did not indicate the 
condition of wounds whether they were healed 
or unhealed. However, it is assumed they were 
unhealed or in the healing process because 
acticoat is used for unhealed wounds in current 
No 
Authors 
(year) 
Setting/ 
Participants  
Study Design  
/ Intervention 
Time 
Characteristics of  
Burn Wound 
Itching 
assess- 
ment Tool Study Result & Limitations 
practice.   
6 
Campanati 
et al. (2013) 
 
Unclear 
setting/ 
30pts 
Non-RCT / 
12weeks 
2nd degree burns in healing 
stage 
unknow
n  
Ozonated oil & hyaluronic acid: Same effect in 
↓PBP 12-week topical application. 
Ozonated oil: more effective than hyaluronic 
acid in preventing post hyperpigmentation. 
Limitation: Lack of a histological comparison 
b/w two agents. 
7 
Cho et al. 
(2014) 
Rehabilitation 
hospital/ 
146pts w/ 
hypertrophic 
scars 
RCT/ 
Average 
34.69days 
All healed burn wound 
(scar) 
VAS Massage therapy ↓ in pain, pruritus, & scar 
characteristics in patients. 
Limitation: Massage given only for short period 
(average: 34.7days), so long-term effects not 
identified. Evolution of hypertrophic scar not 
considered. 
8 
Faraha-nil 
et al. 
(2013) 
Inpatient 
setting/ 
110pts 
Quasi-
experimental 
study / 
1month 
 
2nd degree burn wounds 
Stage of wound healing not 
clear-possibly not healed 
wound considering 
population 
VAS 20-minute Benson muscle relaxation: effective 
in ↓PBP. 
Limitation: No explanation if other methods to 
reduce pruritus along with relaxation tx. No 
explanation of frequency of relaxation tx. 
9 
Field et al. 
(2000) 
Outpatient 
burn center/ 
20pts w/ PBP 
RCT / 
5weeks 
Healed burn wound VAS Massage therapy decreased itching, pain, 
depression & anxiety in burn population w/ 
severe itching. 
Limitation: Further study needed for larger 
sample & long term use of massage therapy. 
10 
Gaida et al. 
(2003) 
 
Outpatient 
setting/ 
19burn pts w/ 
scars 
Pretest-
posttest 
design / 
8weeks 
Healed burn wound (scar) VAS LLLT decreased pain & pruritus among all 
participants. 
Limitation: Further study needed w/ higher 
number of sample & control site from different 
people rather than each person w/ different sites. 
11 
Goutos et 
al.  
(2010) 
Inpatient 
setting/ 
91burn pts 
Cohort, 
observational 
studies/ 
Partial to full thickness 
burn injury. 
Healing stages not 
VAS / 
Itch 
Man 
Monotherapy in PBP: gabapentin monotherapy 
has more effective than chlorpheniramine. 
Polytherapy in PBP: Combination of gabapentin, 
No 
Authors 
(year) 
Setting/ 
Participants  
Study Design  
/ Intervention 
Time 
Characteristics of  
Burn Wound 
Itching 
assess- 
ment Tool Study Result & Limitations 
(50-1st part, 
41-2nd part of 
the study) 
Intervention 
time not 
specified 
specified. Scale cetirizine, & cyproheptadine is more effective 
than combination of 3 antihistamines. 
Limitation: Needs further studies incorporating 
long term f/u of comparing peripherally & 
centrally acting agents in late phases of wound 
healing. 
12 
Gurol et al. 
(2010) 
Inpatient 
setting/ 
63adolescent 
burn pts 
Experimental 
study/ 
5weeks 
2nd-3rd degree burn wound. 
Healing stage not specified. 
VAS 
 
15-minute massage twice per week for 5weeks 
applied to healthy skin around wounds & surface 
of wound decreased PBP in adolescent 
population. 
Limitation: Small sample size & The study did 
not specify wound conditions whether it is 
healed or not. – it is assumed that not all wound 
are healed according to the fact some pts were 
getting standard tx including pain & they were 
enrolled in the study right after admission. 
13 
Hettrick 
(2004) 
Outpatient 
clinic/ 
20pts w/ age 
of 18-75yrs 
RCT 
(Pilot study) 
/ 3weeks 
2nd to 3rd degree recently 
healed burn wound 
VAS TENS reduced PBP. 
Limitation: Hard to generalized to population 
<18 or > 75yrs of age. Can’t apply to 
inflammatory or proliferative stage of wound 
healing. 
14 
Hultman et 
al. 
 (2013) 
Outpatient 
sugical center/  
147burn pts w/ 
hypertrophic 
burn scars 
Cohort 
study/ 
6months 
All healed burn wounds VAS Laser therapy decreased pain, pruritus, pliability, 
& paresthesia in the population. 
Limitation: Long-term effect is uknown, Scar 
component unspecified, Evaluator bias not 
excluded, No control group exists, & Order of 
different lasers not examined. 
15 
Jung et al. 
(2009) 
Inpatient 
rehabilitation /  
19pts treated 
for burn injury 
Retrospectiv
e, 
experimental 
study/ 
2weeks 
Healed burn wounds VAS With Naltrexone therapy, 14 pts reported 
improvement in itching, 5 pts reported no 
change in itching, & 7 pts had side effects.  
Limitation: Small sample size to generalize, 
uncertain to use Naltrexone as the first line of tx.   
No 
Authors 
(year) 
Setting/ 
Participants  
Study Design  
/ Intervention 
Time 
Characteristics of  
Burn Wound 
Itching 
assess- 
ment Tool Study Result & Limitations 
16 
La Salle et 
al.  
(2007) 
Inpatient & 
outpatient 
settings/ 
13burn pts  
age of 19-78  
Experimental 
study/ 
2weeks 
TBSA of 7-70% & all 
grafted burn areas. 
Healing stages not specified 
VAS Naltrexone ↓PBP, frequency & duration of 
itching. 
Limitation: Small sample size, itch intensity or 
qualification of scratching activity to be 
frequently measured, broader range of burn pts, 
long term f/u, & a placebo controlled tx group 
needed. 
17 
Lewis et al.  
(2012) 
 
Inpatient 
setting / 
52burn pts, 
mean age 35 
RCT, 
Pilot study / 
24hours 
Mean TBSA:7.2%, mostly 
partial thickness burn 
wound & newly healed scar 
VAS Medilixir was more effective to minimize PBP 
than aqueous cream. 
Limitation: Small sample size 
18 
Li-Sang et 
al.  
(2006) 
Outpatient 
clinic/ 
45burn pts 
RCT / 
6months 
Post traumatic hypertrophic 
scars 
VAS SGS was effective to reduce thickness, pain, 
itchiness, & pliability of the severe hypertrophic 
scar. 
Limitation: Generalization issue due to small 
size sample & all Chinese participants. Only 16 
burn scars out of 45 scars – can the result be 
applied to specifically to burn scar pts? 
19 
Li-Tsang et 
al.  
(2010) 
participant’s 
routine area /  
104burn pts 
RCT / 
6months 
Burn scars VAS SGS ↓pain & ↓pruritus than ↓scar thickness. 
CTG & PG showed improvement in scar 
thickness after 6-month intervention (CTG>PG). 
Limitation: High drop-rate of participants (19%)  
20 
Mendham 
(2004) 
 
Inpatient 
setting / 
35pediatric 
wound pts 
Experimental 
study/ 
4weeks – 
18months 
Burn wounds and skin loss 
from meningitis. 
Not healed wound 
Unkno
wn 
Gabapentin ↓itching in healing wound & 
↓antihistamine intake in pediatric population. 
Limitation: Gabapentin tx needs cautions for 
worsening behaviors in pediatric population & 
RCT is necessary. 
 21 
Nedelec et 
al.  
(2012) 
Not clear / 
18pts having 
PBP treated in 
the hospital   
RCT,  
Pilot study / 
4weeks 
All healed burn wounds 
(scars) 
Yosipo-
vitch’s 
question
-naire 
Provase ↓PBP in frequency & episode of itch, & 
duration of itch. 
Limitation: Small pilot study, single center & 
convenience population, short period of data 
collection (4wks), & no classification b/w acute 
& chronic pruritus in post burn population. 
No 
Authors 
(year) 
Setting/ 
Participants  
Study Design  
/ Intervention 
Time 
Characteristics of  
Burn Wound 
Itching 
assess- 
ment Tool Study Result & Limitations 
22 
Ogawa & 
Hyaku-
soku (2008) 
Inpatient 
setting/  
14pts w/ 
hypertrophic 
scars from 
burns 
Prospective, 
Cohort study 
/ 2months 
All healed burn wounds 
(scars) 
VAS Mugwort lotion decreased itching & sleep 
disturbance.  
Limitation: Need to continue to evaluate effects 
& mechanism of Mugwort lotion. Further 
studies needed for evaluating this lotion. 
23 
Ratcliff et 
al.  
(2005) 
Inpatient 
setting / 
286burn 
children 
Retrospect-
ive chart 
review / 
Varied  
All burn wounds 
: Various wound stages 
Itch 
Man 
Scale 
Management protocols for pain, anxiety, stress, 
& iching in pediatric population offers data to 
reduce burn related symptoms in the future. 
i.e: Itching management protocol for children; 
1)Moisturizing body shampoo, lotions, & topical 
ointments (not hydrocortisone creams) 
2)Diphenhydramine 1.25mg/kg/dose po Q 6h 
3)If itch remains poorly controlled, subsequently 
add hydroxyzine 0.6mg/kg/dose po q 6h, then 
cyproheptadine 0.1mg/kg/dose q6h so that one 
of the medications is given q2hrs 
Limitation: Possibility of incomplete data due to 
study design 
24 
Roh et al. 
(2007) 
Outpatient 
clinic/ 
35burn pts 
Pretest – 
posttest / 
3months 
Burn scars from partial or 
full thickness burns on 
forearm or hand 
Itch 
man 
Scale 
SRMT decreased PBP in burn victims with scars 
on forearms or hands. 
Limitation: Small sample size & needs more 
reliable & objective burn-scar assessment tools. 
25 
Waked et 
al.  
(2013) 
Inpatient 
setting / 
40burn pts 
RCT/ 
1month 
2nd & 3rd degree burn 
wounds, 10-15%TBSA. – 
All Healed scars 
5-D Itch 
scale 
TAP was as useful as TENS to reduce PBP 
Limitation: No control group in the study & 
small sample noted. 
26 
Whitaker 
(2001) 
 
Inpatient 
setting / 
One case 
Case study / 
2weeks 
Healed 70%TBSA flame 
burn wound (scar) 
VAS 2 weeks of TENS was effective in ↓PBP. 
Day #1: 62.5% decreased in itching within 4hrs 
of application. 
Day #2: 88% decreased within 4hrs of 
application. 
Day #3: No itching within 4hrs of application. 
Limitation: More case studies or full-scale study 
No 
Authors 
(year) 
Setting/ 
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Study Design  
/ Intervention 
Time 
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Burn Wound 
Itching 
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needed. 
Notes. CTG = combined pressure therapy and silicone gel sheeting group; h = hour; hrs = hours; H1 = histamine 1; H2 = histamine 2; LLLT = low level laser 
therapy; PBP = post burn pruritus; PG = pressure therapy group; po = orally; pts = patients; Q = every; RCT = randomized controlled trial; SGS = silicone gel 
sheeting; SRMT = skin rehabilitation massage therapy; TAP = triamcinolone acetonide phonophoresis; TBSA = total body surface area; TENS = 
transcutaneous electrical nerve stimulation; VAS = Visual Analog Scale; wks = weeks; w/ = with; ↓= decreased. 
 
  Table 2. Post Burn Pruritus Relief Protocol Guideline (Recommended Dosage) 
 
Wound Stage  Treatment Plan 
Recommended Dosage  
 (refer to article No. in Table 1) 
Pre-healing 
stage 
Massage to intact skin 15minutes/day, 2days/week, 5weeks or as needed. 
(12) 
Benson Muscle Relaxation therapy 20minutes daily for 1month or as needed  
(8) 
Pharmacological treatment  
 
- Pregabalin alone 
- Pregabalin & two antihistamines  
 
 
- Gabapentin alone 
- Gabapentin & H1 blocker 
 
- Gabapentin & two H1 blockers 
 
- Combination of H1 & H2 
blockers  
 
(1, 2, 4, 11, 20, 23) 
 
- 150-300mg/day (divided by 2 or 3 times)  
- Pregabalin (same dose),  
Cetirizine 10-20mg/day (one or twice a day), & 
Pheniramine 25mg/day before sleep  
- 300-900mg/day (adult), 5-10mg/kg/day (child) 
- Gabapentin (same dose) & Cetirizine 10-20mg/day 
- Gabapentin & Cetirizine (same doses) & 
Cyproheptadine 4mg every 6hours 
- Cetirizine: 20mg/day (adult) & 10mg/day (pediatric 
patient), & 
Cimetidine: 1200mg/day, divided by 4 (adult), 
30mg/kg/day, divided by 4 (child) 
Naltrexone (supplemental 
pharmacological treatment) 
25-50mg/day before sleep for 2weeks (15, 16) 
Healing stage All treatments for pre-healing stage 
& Topical agents (Ozonated oil or 
Hyaluronic acid gel 0.2%) 
Ozonated oil 2drops/cm²once a day or 
Hyaluronic  acid gel ½ finger tip/cm²daily 
For 12 weeks or as needed (6) 
Healed stage Benson muscle relaxation  Same dose as above (8) 
Massage to healed wound 15-30minutes, 1-3times/week for 5-12weeks  (7, 9, 24)  
Nanocrystalline silver  for 2weeks (5) 
LLLT or  
regular Laser Therapy 
LLLT: 2times/week for 8weeks (10)  
Regular laser therapy: once per month for 6 month 
(14)  
TENS  Once a day for 2-3weeks (13, 26) 
TAP  3times/week for 1month (25) 
SGS  Wear 12-24hours/day for 6months (18, 19) 
Pressure garments  Apply as needed (19) 
Topical agents  
- Medilixir  
- Mugwort lotion  
- Provase  
- Ozonated oil  
- Hyaluronic acid gel 0.2% 
 
- Once daily for 2weeks (17) 
- 2 times/day for 2months (22) 
- 3 times/day for 4weeks (21) 
- 2drops/cm²once daily (6) 
- ½finger tip/cm² daily (6) 
After failure 
with above 
Botulinum toxin One time dose (3) 
 
